Since we demonstrated in vivo that mouse Esm1 inhibited HCC T cell infiltration and activation, we asked whether Esm1 mediated T cell activation through ICAM-1/LFA-1 pathway. This evidence concerns the gene ITGB2 and hepatocellular carcinoma.